[New Zimbabwe] THE experimental M72/AS01 tuberculosis (TB) vaccine has shown a favourable safety profile in people living with HIV who are on antiretroviral therapy (ART), boosting prospects for TB prevention in one of the most vulnerable groups.

Originally published by Zimbabwe Independent. Read original article